STING1 and colonic neoplasm: Similarly, Kim et al. examined the therapeutic effectiveness of a STING agonist in combination with anti-PD-1 antibody therapy after implanting MC38 colon cancer cells intraperitoneally into C57BL/6 mice, causing the mice to develop PC with malignant ascites.